Generalized fluctuation test for deciphering phenotypic switching within cell populations

NIH RePORTER · NIH · R35 · $391,362 · view on reporter.nih.gov ↗

Abstract

Generalized fluctuation test for deciphering phenotypic switching within cell populations The inherent probabilistic nature of biochemical reactions coupled with low-copy number components results in significant random fluctuations (noise) in mRNA/protein levels inside individual cells. How cellular biochemical processes function reliably in the face of such randomness is an intriguing fundamental problem. A long-term vision of our lab is to develop new mathematical and computational tools for studying stochastic dynamics of cellular biochemical processes, and use these tools to systematically understand how noise affects biological function and phenotype. As a consequence of noise in gene product levels, single cells within an isoclonal population can differ in their expression profile and reside in different pheno- typic states. The dynamic nature of this intercellular variation, where individual cells can transition between different states over time makes it a particularly hard phenomenon to characterize. Unexpectedly, phenotypic heterogeneity within a population can play important functional roles in diverse biological processes, from driving genetically-identical cells to different cell fates to allowing microbes and cancer cells to hedge their bets against uncertain environmental changes. The Luria-Delbrück experiment, also called the “Fluctuation Test", introduced 75 years ago, demonstrated that genetic mu- tations arise randomly in the absence of selection – rather than in response to selection – and led to a Nobel Prize. The innovation of this project is to leverage this classical experiment in conjunction with mathematical modeling to char- acterize reversible and irreversible switching between cell states. The key advantage of the proposed method is that it is general enough to be applied to any proliferating cell type, and only involves making a single endpoint measurement. This is especially important for scenarios where a measurement involves killing the cell (for example, assaying whether a bacte- rial cell is in a drug-sensitive or drug-tolerant state or doing RNA-sequencing), and hence the state of the same cell cannot be measured at different time points. The project will develop mathematical tools for characterizing phenotypic switching between an arbitrary number of states using the fluctuation test, and such techniques will for the first time differentiate between an irreversible cell-state transition via genetic alterations vs. a reversible epigenetic transition. These tools will be first benchmarked with in-silico generated data and then applied on experimental datasets investigating diverse prob- lems, including characterizing drug-tolerant states in bacterial/fungal cells, understanding differences in viral susceptibility between single human cells within the same clonal population, and uncovering the transient dynamics of stem cell states that bias individual cells to different differentiation fates. Our preliminary work revea...

Key facts

NIH application ID
10552300
Project number
1R35GM148351-01
Recipient
UNIVERSITY OF DELAWARE
Principal Investigator
Abhyudai Singh
Activity code
R35
Funding institute
NIH
Fiscal year
2023
Award amount
$391,362
Award type
1
Project period
2023-03-01 → 2027-12-31